PE20040799A1 - Derivados de tetrahidroquinolina como moduladores del receptor fhs - Google Patents
Derivados de tetrahidroquinolina como moduladores del receptor fhsInfo
- Publication number
- PE20040799A1 PE20040799A1 PE2004000014A PE2004000014A PE20040799A1 PE 20040799 A1 PE20040799 A1 PE 20040799A1 PE 2004000014 A PE2004000014 A PE 2004000014A PE 2004000014 A PE2004000014 A PE 2004000014A PE 20040799 A1 PE20040799 A1 PE 20040799A1
- Authority
- PE
- Peru
- Prior art keywords
- tetrahydro
- biphenyl
- trimethyl
- phenyl
- carboxyl acid
- Prior art date
Links
- 150000003530 tetrahydroquinolines Chemical class 0.000 title abstract 2
- 239000002253 acid Substances 0.000 abstract 3
- -1 2-DIMETHYLAMINO-ETHOXY Chemical class 0.000 abstract 2
- 241000670727 Amida Species 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 abstract 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000035558 fertility Effects 0.000 abstract 1
- 229940028334 follicle stimulating hormone Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE REFIERE A DERIVADOS DE TETRAHIDROQUINOLINA DE FORMULA I, INCLUYENDO SUS SALES FARMACEUTICAMENTE ACEPTABLES, EN DONDE R1 Y R2 SON H o Me; R3 ES HETEROCICLOALQUIL(C2-C6)-ALQUIL(C1-C4), HETEROARIL(C2-C5)-ALQUIL(C1-C4), ENTRE OTROS; R4 ES HETEROARIL (C2-C5), CICLOALQUIL (C2-C8), HETEROCICLOALQUIL (C2-C6), ENTRE OTROS. SON COMPUESTOS PREFERIDOS: BIFENIL-4-ACIDO CARBOXILICO {1-ACETIL-4-[4-(2-DIMETILAMINO-ETOXI)-FENIL]-2,2,2-TRIMETIL-1,2,3,4-TETRAHIDRO-QUINOLIN-6-IL}AMIDA; BIFENIL-4-ACIDO CARBOXILICO {1-ACETIL-4-[4-(2-DIMETILAMINO-PROPOXI)-FENIL]-2,2,4-TRIMETIL-1,2,3,4-TETRAHIDRO-QUINOLINA-6-IL}AMIDA; BIFENIL-4-ACIDO CARBOXILICO {1-ACETIL-2,2,4-TRIMETIL-4-[4-(3-MORFOLINA-4-IL-PROPOXI)-FENIL]-1,2,3,4-TETRAHIDRO-QUINOLINA-6-IL}AMIDA; ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. ESTOS COMPUESTOS MODULAN LA ACTIVIDAD DEL RECEPTOR FSH (HORMONA FOLICULO ESTIMULANTE) Y SON UTILES PARA LA REGULACION DE LA FERTILIDAD
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02102865 | 2002-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20040799A1 true PE20040799A1 (es) | 2004-12-02 |
Family
ID=38799446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2004000014A PE20040799A1 (es) | 2002-12-20 | 2004-01-05 | Derivados de tetrahidroquinolina como moduladores del receptor fhs |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7674909B2 (es) |
| EP (1) | EP1578727B1 (es) |
| JP (1) | JP4545000B2 (es) |
| AR (1) | AR042629A1 (es) |
| AT (1) | ATE392416T1 (es) |
| AU (1) | AU2003303221B2 (es) |
| BR (1) | BR0317514A (es) |
| CA (1) | CA2508923C (es) |
| CL (1) | CL43546B (es) |
| DE (1) | DE60320457T2 (es) |
| DK (1) | DK1578727T3 (es) |
| ES (1) | ES2304544T3 (es) |
| MX (1) | MXPA05006772A (es) |
| NZ (1) | NZ540577A (es) |
| PE (1) | PE20040799A1 (es) |
| PL (1) | PL376997A1 (es) |
| PT (1) | PT1578727E (es) |
| RS (1) | RS51196B (es) |
| RU (1) | RU2328487C2 (es) |
| SI (1) | SI1578727T1 (es) |
| TW (1) | TWI322012B (es) |
| UA (1) | UA80303C2 (es) |
| WO (1) | WO2004056779A2 (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4523273B2 (ja) * | 2001-07-02 | 2010-08-11 | ナームローゼ・フエンノートチヤツプ・オルガノン | テトラヒドロキノリン誘導体 |
| TWI306855B (en) * | 2002-12-20 | 2009-03-01 | Organon Nv | Tetrahydroquinoline derivatives |
| DE10260739B3 (de) | 2002-12-23 | 2004-09-16 | Outokumpu Oy | Verfahren und Anlage zur Herstellung von Metalloxid aus Metallverbindungen |
| US7691848B2 (en) | 2005-03-02 | 2010-04-06 | Wyeth | Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists |
| CA2606521C (en) | 2005-05-04 | 2012-09-18 | N.V. Organon | Dihydropyridine derivatives |
| UA92007C2 (ru) * | 2005-05-04 | 2010-09-27 | Н.В. Органон | Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодности |
| UA92008C2 (en) * | 2005-05-04 | 2010-09-27 | Н.В. Органон | 4-PHENYL-5-OXO-l,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY |
| UA92009C2 (ru) * | 2005-05-04 | 2010-09-27 | Н.В. Органон | Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодия |
| JP2008540567A (ja) | 2005-05-12 | 2008-11-20 | ワイス | 卵胞刺激ホルモン受容体（ｆｓｈ−ｒ）アンタゴニストとしてのピロロベンゾジアゼピンおよびヘテロ環状カルボキサミド誘導体 |
| EP1879897A1 (en) * | 2005-05-12 | 2008-01-23 | Wyeth a Corporation of the State of Delaware | Pyrrolobenzodiazepines and heteroaryl, aryl and cycloalkylamino ketone derivatives as follicle stimulating hormone receptor -(fish-r) antagonists |
| US7678787B2 (en) | 2005-06-09 | 2010-03-16 | Wyeth | Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists |
| TW200918058A (en) | 2007-08-31 | 2009-05-01 | Organon Nv | TSH receptor antagonizing tetrahydroquinoline compounds |
| US20100061976A1 (en) * | 2008-07-24 | 2010-03-11 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject |
| WO2015074081A1 (en) | 2013-11-18 | 2015-05-21 | Bair Kenneth W | Benzopiperazine compositions as bet bromodomain inhibitors |
| HUE053645T2 (hu) | 2013-11-18 | 2021-07-28 | Forma Therapeutics Inc | Tetrahidrokinolin kompozíciók mint BET bromodomén inhibitorok |
| CA3075880A1 (en) | 2017-09-15 | 2019-03-21 | Forma Therapeutics, Inc. | Tetrahydro-imidazo quinoline compositions as cbp/p300 inhibitors |
| CA3105099A1 (en) | 2018-06-29 | 2020-01-02 | Forma Therapeutics, Inc. | Inhibiting creb binding protein (cbp) |
| EP3937940A4 (en) | 2019-03-15 | 2022-12-21 | Forma Therapeutics, Inc. | Inhibiting cyclic amp-responsive element-binding protein (creb) |
| US11795168B2 (en) | 2020-09-23 | 2023-10-24 | Forma Therapeutics, Inc. | Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP) |
| US11801243B2 (en) | 2020-09-23 | 2023-10-31 | Forma Therapeutics, Inc. | Bromodomain inhibitors for androgen receptor-driven cancers |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2686182A (en) | 1950-12-07 | 1954-08-10 | Basf Ag | O-hydroxy-dihydro-quinoline carboxylic acids |
| ES2054784T3 (es) | 1987-08-08 | 1994-08-16 | Akzo Nv | Un metodo para la fabricacion de un implante. |
| CZ285937B6 (cs) * | 1992-01-16 | 1999-12-15 | Hoechst Aktiengesellschaft | Arylcykloalkylové deriváty, způsob přípravy těchto derivátů a jejich použití |
| HUT78117A (hu) * | 1994-12-22 | 1999-11-29 | Ligand Pharmaceuticals Incorporated | Szteroid receptor modulátor kinolin- és kondenzált kinolinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények |
| IL141063A (en) * | 1998-08-07 | 2005-06-19 | Applied Research Systems | Derivatives of pyrrolidine-2-carboxylic acid and piperidine-2-carboxylic acids and pharmaceutical compositions comprising said derivatives for treating infertility |
| US6200963B1 (en) | 1999-03-31 | 2001-03-13 | American Home Products Corporation | Aryl sulfonic acids as FSH antagonists |
| JP4523273B2 (ja) * | 2001-07-02 | 2010-08-11 | ナームローゼ・フエンノートチヤツプ・オルガノン | テトラヒドロキノリン誘導体 |
| TWI306855B (en) | 2002-12-20 | 2009-03-01 | Organon Nv | Tetrahydroquinoline derivatives |
-
2003
- 2003-12-15 TW TW092135440A patent/TWI322012B/zh not_active IP Right Cessation
- 2003-12-16 UA UAA200505286A patent/UA80303C2/uk unknown
- 2003-12-16 PL PL376997A patent/PL376997A1/pl not_active Application Discontinuation
- 2003-12-16 AU AU2003303221A patent/AU2003303221B2/en not_active Ceased
- 2003-12-16 RU RU2005122924/04A patent/RU2328487C2/ru not_active IP Right Cessation
- 2003-12-16 BR BR0317514-6A patent/BR0317514A/pt not_active IP Right Cessation
- 2003-12-16 PT PT03808299T patent/PT1578727E/pt unknown
- 2003-12-16 US US10/540,335 patent/US7674909B2/en not_active Expired - Lifetime
- 2003-12-16 JP JP2004561498A patent/JP4545000B2/ja not_active Expired - Fee Related
- 2003-12-16 EP EP03808299A patent/EP1578727B1/en not_active Expired - Lifetime
- 2003-12-16 AT AT03808299T patent/ATE392416T1/de active
- 2003-12-16 WO PCT/EP2003/051024 patent/WO2004056779A2/en not_active Ceased
- 2003-12-16 SI SI200331217T patent/SI1578727T1/sl unknown
- 2003-12-16 DK DK03808299T patent/DK1578727T3/da active
- 2003-12-16 NZ NZ540577A patent/NZ540577A/en not_active IP Right Cessation
- 2003-12-16 ES ES03808299T patent/ES2304544T3/es not_active Expired - Lifetime
- 2003-12-16 RS YUP-2005/0458A patent/RS51196B/sr unknown
- 2003-12-16 DE DE60320457T patent/DE60320457T2/de not_active Expired - Lifetime
- 2003-12-16 CA CA2508923A patent/CA2508923C/en not_active Expired - Lifetime
- 2003-12-16 MX MXPA05006772A patent/MXPA05006772A/es active IP Right Grant
- 2003-12-18 CL CL200302684A patent/CL43546B/es active
- 2003-12-19 AR ARP030104728A patent/AR042629A1/es unknown
-
2004
- 2004-01-05 PE PE2004000014A patent/PE20040799A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20060167047A1 (en) | 2006-07-27 |
| ES2304544T3 (es) | 2008-10-16 |
| WO2004056779A3 (en) | 2004-08-12 |
| EP1578727B1 (en) | 2008-04-16 |
| PT1578727E (pt) | 2008-05-23 |
| AR042629A1 (es) | 2005-06-29 |
| DE60320457D1 (de) | 2008-05-29 |
| CA2508923A1 (en) | 2004-07-08 |
| EP1578727A2 (en) | 2005-09-28 |
| CL43546B (es) | 2005-04-08 |
| JP4545000B2 (ja) | 2010-09-15 |
| US7674909B2 (en) | 2010-03-09 |
| MXPA05006772A (es) | 2005-09-08 |
| WO2004056779A2 (en) | 2004-07-08 |
| RU2328487C2 (ru) | 2008-07-10 |
| CA2508923C (en) | 2011-09-20 |
| AU2003303221A1 (en) | 2004-07-14 |
| RS20050458A (sr) | 2007-08-03 |
| TW200418471A (en) | 2004-10-01 |
| UA80303C2 (en) | 2007-09-10 |
| RU2005122924A (ru) | 2006-01-27 |
| AU2003303221B2 (en) | 2009-09-17 |
| PL376997A1 (pl) | 2006-01-23 |
| JP2006512346A (ja) | 2006-04-13 |
| TWI322012B (en) | 2010-03-21 |
| ATE392416T1 (de) | 2008-05-15 |
| BR0317514A (pt) | 2005-11-16 |
| SI1578727T1 (sl) | 2008-08-31 |
| DK1578727T3 (da) | 2008-08-04 |
| DE60320457T2 (de) | 2009-06-04 |
| NZ540577A (en) | 2006-12-22 |
| RS51196B (sr) | 2010-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20040799A1 (es) | Derivados de tetrahidroquinolina como moduladores del receptor fhs | |
| US6599910B1 (en) | Substituted triazole compounds | |
| ES2328471T3 (es) | Pirimidinas aril sustituidas y uso de las mismas. | |
| JP5980236B2 (ja) | ジアミノピリミジン誘導体及びその製造方法 | |
| PE20010741A1 (es) | Derivados de piperazina como antagonistas de taquicininas | |
| AR039567A1 (es) | Derivados de sulfonilamino como nuevos inhibidores de histona deacetilasa, composicion farmaceutica y procedimiento de preparacion del compuesto | |
| PE20060777A1 (es) | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas | |
| AR031680A1 (es) | Utilizacion de acrilamidas de quinuclidina para la preparacion de medicamentos, compuestos y composicion farmaceutica | |
| NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
| AR057661A1 (es) | Un derivado de oxima y sus preparaciones | |
| PE20050420A1 (es) | Fenacilo 2-hidroxi-3-diaminoalcanos | |
| PE20061150A1 (es) | Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1) | |
| PE20081315A1 (es) | Derivados de benzimidazol como antagonistas de vr-1 | |
| PE20091243A1 (es) | Compuesto heterociclico fusionado | |
| EP1233951A1 (en) | 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors | |
| ES2770047T3 (es) | Compuestos de azetidiniloxifenilpirrolidina | |
| PE20060589A1 (es) | FENILAMINOTIAZOLES SUSTITUIDOS COMO AGONISTAS DE ADENOSINA A1 Y A2b | |
| EA039908B1 (ru) | Азаиндазольные соединения для применения при повреждениях сухожилий и/или связок | |
| AR049346A1 (es) | 3-amino-1-arilpropil-indoles como inhibidores de reabsorcion de monoaminas | |
| RU2368608C2 (ru) | Производные пиперидина в качестве модуляторов хемокинового рецептора ccr5 | |
| PE20061163A1 (es) | Compuestos de n-sulfonilaminofeniletil-2-fenoxiacetamida sustituidos | |
| AR008621A1 (es) | Un compuesto derivado de amina succinica, un procedimiento para llevar a cabo su preparacion y una composicion farmaceutica que comprende dichocompuesto | |
| EP0711770A1 (de) | Adhäsionsrezeptor-Antagonisten | |
| PE20050329A1 (es) | Derivados de nicotinamida como inhibidores de fosfodiesterasa pde4 | |
| AR037459A1 (es) | Antagonistas vi del receptor ccr-3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |